Literature DB >> 28943810

Type 1 Diabetes - A Clinical Perspective.

Lindy Kahanovitz1,2, Patrick M Sluss3, Steven J Russell2.   

Abstract

Type 1 diabetes is a disease in which autoimmune destruction of pancreatic β-cells leads to insulin deficiency. Controlling blood glucose with an acceptable range is a major goal of therapy. Measurements of hemoglobin A1c and blood glucose levels are used for both the diagnosis and the long-term management of the disease. This chapter briefly describes the pathophysiology, diagnosis, and management of type 1 diabetes.

Entities:  

Keywords:  C-peptide; Type 1 diabetes; continuous glucose monitoring; hemoglobin A1c; insulin; point of care; self monitoring blood glucose

Year:  2017        PMID： 28943810      PMCID： PMC5606981          DOI： 10.1097/POC.0000000000000125

Source DB:  PubMed          Journal:  Point Care        ISSN： 1533-029X


  32 in total

1.  Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation.

Authors:  E Bonifacio; M Scirpoli; K Kredel; M Füchtenbusch; A G Ziegler
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

Review 2.  2. Classification and Diagnosis of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-01       Impact factor: 19.112

3.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

4.  Improving outcomes with POCT for HbA1c and blood ketone testing.

Authors:  Lori Laffel
Journal:  J Diabetes Sci Technol       Date:  2007-01

5.  A bihormonal closed-loop artificial pancreas for type 1 diabetes.

Authors:  Firas H El-Khatib; Steven J Russell; David M Nathan; Robert G Sutherlin; Edward R Damiano
Journal:  Sci Transl Med       Date:  2010-04-14       Impact factor: 17.956

6.  Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

Authors: 
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

7.  Feasibility of automating insulin delivery for the treatment of type 1 diabetes.

Authors:  Garry M Steil; Kerstin Rebrin; Christine Darwin; Farzam Hariri; Mohammed F Saad
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

8.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

9.  Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.

Authors:  Diana B Petitti; Georgeanna J Klingensmith; Ronny A Bell; Jeanette S Andrews; Dana Dabelea; Giuseppina Imperatore; Santica Marcovina; Catherine Pihoker; Debra Standiford; Beth Waitzfelder; Elizabeth Mayer-Davis
Journal:  J Pediatr       Date:  2009-07-29       Impact factor: 4.406

Review 10.  The artificial pancreas: current status and future prospects in the management of diabetes.

Authors:  Thomas Peyser; Eyal Dassau; Marc Breton; Jay S Skyler
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691
View more
  17 in total

Review 1.  Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer.

Authors:  Rajeswari Raguraman; Akhil Srivastava; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-08-08       Impact factor: 15.470

2.  Study protocol of a randomized controlled clinical trial investigating the effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes.

Authors:  Masoud Khorshidi; Aliakbar Sayyari; Beheshteh Olang; Mohammad Reza Alaei; Sakineh Shab-Bidar; Mitra Khalili; Masoud Salehi; Naheed Aryaeian
Journal:  Trials       Date:  2021-12-27       Impact factor: 2.279

Review 3.  Smartphone Apps for Diabetes Medication Adherence: Systematic Review.

Authors:  Sheikh Mohammed Shariful Islam; Vinaytosh Mishra; Muhammad Umer Siddiqui; Jeban Chandir Moses; Sasan Adibi; Lemai Nguyen; Nilmini Wickramasinghe
Journal:  JMIR Diabetes       Date:  2022-06-21

Review 4.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

5.  Effect of alginate matrix engineered to mimic the pancreatic microenvironment on encapsulated islet function.

Authors:  Kevin Enck; Riccardo Tamburrini; Chaimov Deborah; Carlo Gazia; Alec Jost; Fatma Khalil; Abdelrahman Alwan; Giuseppe Orlando; Emmanuel C Opara
Journal:  Biotechnol Bioeng       Date:  2020-12-25       Impact factor: 4.530

Review 6.  The prognostic outcome of 'type 2 diabetes mellitus and breast cancer' association pivots on hypoxia-hyperglycemia axis.

Authors:  Ilhaam Ayaz Durrani; Attya Bhatti; Peter John
Journal:  Cancer Cell Int       Date:  2021-07-05       Impact factor: 5.722

7.  Moderate intensity exercise in hypoxia increases IGF-1 bioavailability and serum irisin in individuals with type 1 diabetes.

Authors:  Aleksandra Żebrowska; Marcin Sikora; Anna Konarska; Anna Zwierzchowska; Tomasz Kamiński; Anna Robins; Barbara Hall
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-27       Impact factor: 3.565

Review 8.  Antidiabetic Potential of Syzygium sp.: An Overview.

Authors:  Azrin S Zulcafli; Chooiling Lim; Anna P Ling; Soimoi Chye; Rhunyian Koh
Journal:  Yale J Biol Med       Date:  2020-06-29

9.  Serum levels of the high-mobility group box 1 protein (HMGB1) in children with type 1 diabetes mellitus: case-control study.

Authors:  Igor Marjanac; Robert Lovrić; Jerko Barbić
Journal:  Cent Eur J Immunol       Date:  2019-04-15       Impact factor: 2.085

Review 10.  Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence.

Authors:  Simon Alesi; Drishti Ghelani; Kate Rassie; Aya Mousa
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.